ALC

Alcon Inc
NYSE

Real-time Quotes | Nasdaq Last Sale

56.55
-0.85
-1.48%
Closed 16:00 09/23 EDT
OPEN
57.17
PREV CLOSE
57.40
HIGH
57.43
LOW
56.50
VOLUME
1.19M
TURNOVER
--
52 WEEK HIGH
65.37
52 WEEK LOW
39.37
MARKET CAP
27.66B
P/E (TTM)
177.22
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Tracking David Rolfe's Wedgewood Partners Portfolio - Q2 2020 Update
Wedgewood Partners’ 13F portfolio value increased from $528M to $590M this quarter.David Rolfe increased Bristol-Myers Squibb while dropping Booking Holdings and FLEETCOR Technologies.Their top five positions are at 28% of the overall portfolio.
Seekingalpha · 3d ago
Alcon (ALC) Presents At Morgan Stanley Annual Global Healthcare Conference - Slideshow
The following slide deck was published by Alcon Inc. in conjunction with this event.
Seekingalpha · 5d ago
Analyst Report: Alcon Inc.
Find the latest Alcon Inc. (ALC) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance
Morningstar Research · 09/08 21:38
Ocugen Needs Too Much Time and Too Much Cash
InvestorPlace · 08/28 18:42
Alcon (ALC) Has Fallen 5% in Last One Year, Underperforms Market
If you are looking for the best ideas for your portfolio you may want to consider some of Wedgewood Partners top stock picks. Wedgewood Partners, an investment management firm, is bullish on Alcon Inc (NYSE:ALC) stock. In its Q2 2019 investor letter – you can download a copy here – the firm discussed
Insider Monkey · 08/27 18:17
Bausch Spinoff Plan Could Double Your Money, J.P. Morgan Says
Move would help eye-care business get the higher valuation now enjoyed by Alcon and Cooper.
marketwatch.com · 08/24 15:20
Theres a Reason Why Ocugen Is a Last Resort in Eye Care
The last time I wrote about Ocugen (NASDAQ:OCGN), OCGN stock was up 34% only halfway through the month of January. Since then, a whole bunch of stuff happened, some of it good, some of it bad, none of it worthy of you betting the farm on the clinical-stage biopharma company.Source: luchschenF / Shutterstock.com
InvestorPlace · 08/21 13:24
Alcon and Actress Katherine McNamara Encourage Consumers to See What Happens with PRECISION1® Contact Lenses
Business Wire · 08/20 13:00
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ALC. Analyze the recent business situations of Alcon Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 18 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ALC stock price target is 64.25 with a high estimate of 71.00 and a low estimate of 47.50.
EPS
Institutional Holdings
Institutions: 0
Institutional Holdings: 0
% Owned: 0.00%
Shares Outstanding: 489.10M
TypeInstitutionsShares
Increased
0
0
New
0
0
Decreased
0
0
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-1.14%
Healthcare Equipment & Supplies
-1.44%
Key Executives
Chairman/Independent Director
Duncan Jackman
President/Chief Executive Officer
Gregg Ruhl
Chief Financial Officer
Peter Winkley
Senior Vice President - Finance
Mario Battista
Senior Vice President/General Counsel
J. Wesley Newton
Senior Vice President
Brad Tiffin
Vice President - Finance
Christopher Lazarz
Vice President
Bruce Partridge
Vice President
Steve Wright
Vice President - Administration
Fredrik Hanson
Other
Charlie Bungard
Other
Jeffrey DeRosario
Other
Joshua Juel
Other
Darren Pearson
Other
Cathy Smith
Independent Director
Richard Carty
Independent Director
Paul Gurtler
Independent Director
E. M. Blake Hutcheson
Independent Director
Mark McQueen
Independent Director
Clive Rowe
Independent Director
Harold Stephen
Independent Director
Eric Stevenson
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
--
Dividend CAD 0.12
05/14/2020
--
Dividend CAD 0.12
02/13/2020
--
Dividend CAD 0.11
11/15/2019
--
Dividend CAD 0.1
08/19/2019
05/03/2019
Dividend CAD 0.1
05/16/2019
--
Dividend CAD 0.1
02/14/2019
02/09/2018
Dividend CAD 0.09
02/14/2018
11/03/2017
Dividend CAD 0.09
11/16/2017
08/03/2017
Dividend CAD 0.08
08/16/2017
05/05/2017
Dividend CAD 0.08
05/16/2017
02/06/2017
Dividend CAD 0.07
02/13/2017
11/09/2016
Dividend CAD 0.07
11/15/2016
08/09/2016
Dividend CAD 0.07
08/16/2016
05/10/2016
Dividend CAD 0.07
05/16/2016
02/09/2016
Dividend CAD 0.07
02/11/2016
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About ALC
Alcon AG is a Switzerland-based company specialized in the medical industry. The Company operates mainly as an eye care device company. Alcon AG reports its activities into two segments: Surgical and Vision Care. The surgical segment provides a line of ophthalmic surgical products that enable surgeons to achieve accurate results. Its surgical portfolio includes technologies and devices for cataract, retinal, refractive surgery, as well as advanced technology intraocular lenses (ATIOLs) to treat cataracts and refractive errors, such as presbyopia and astigmatism. The surgical segment also includes advanced viscoelastics, surgical solutions, surgical packs and other disposable products for cataract and vitreoretinal surgery. The Vision Care segment manufactures contact lenses and lens care products, such as products for dry eye, contact lens care, ocular allergies, as well as ocular vitamins and redness relievers. The Company also offers continuing education for eye care professionals.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Alcon AG stock information, including NYSE:ALC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ALC stock methods without spending real money on the virtual paper trading platform.